Company Overview and News

 
LG to launch V40 ThinQ smartphone in U.S. on Oct. 18

2018-10-09 english.yonhapnews.co.kr
SEOUL, Oct. 9 (Yonhap) -- LG Electronics Inc. said Tuesday that it will launch its new flagship smartphone, the V40 ThinQ, in the United States on Oct. 18, ahead of its release in South Korea.
39IB LGEAF LGEPF LGLD LGEJY LGEIY

3
IT H/W: Key Takeaways From Our Visits To Japan/Taiwan

2018-10-08 seekingalpha
DRAM contract prices to fall in 4Q18; DRAM and NAND market to grow 10.1% and 3.9% YoY in 2019.
XIACY 39IB SSNLF JPDYY TOELY SUOPY LGEAF AAPL 6740 INTC TOELF LGEIY LGEPF HXSCF AUO TOSYY BC94 SHCAY SMSN WBEMF JNNDF LGLD 8035 LGEJY HXSCL SMSD

1
Seoul shares down 0.34 pct in late morning trade

2018-10-08 english.yonhapnews.co.kr
SEOUL, Oct. 8 (Yonhap) -- South Korean stocks traded 0.34 percent lower late Monday morning as key shares went south.
39IB LGEAF SKMD LGEPF HYUO SKM LGLD HYUP LGEJY LGEIY HYUD

 
LG Electronics airs BTS video in New York's Times Square

2018-10-08 english.yonhapnews.co.kr
SEOUL, Oct. 8 (Yonhap) -- LG Electronics Inc. said Monday it aired a special video dedicated to South Korean boy band BTS at Times Square In New York to coincide with the K-pop group's world tour.
39IB LGEAF LGEPF LGLD LGEJY LGEIY

 
LG washers, dryers top Consumer Reports list

2018-10-07 english.yonhapnews.co.kr
SEOUL, Oct. 7 (Yonhap) -- LG Electronics Inc., South Korea's leading consumer appliance maker, has dominated the list of best washing machines and dryers by a U.S. consumer advocacy magazine.
39IB LGEAF LGEPF LGLD LGEJY LGEIY

14
Solar Power International Serves Up Sizzle

2018-10-05 seekingalpha - 1
Last week I was privileged to attend Solar Power International and Energy Storage International – aka Smart Energy Week. Companies including Canadian Solar (CSIQ), Jinko (JKS), LG (OTC:LGEAF), Panasonic (OTCPK:PCRFF), and SolarEdge (SEDG) spared no expense on displaying their latest products.
39IB LGEAF PCRFF LGEPF SPWR LGLD ENPH CSIQ LGEJY LGEIY

1
(2nd LD) LG Electronics operating profit up 44.4 pct in Q3

2018-10-05 english.yonhapnews.co.kr
SEOUL, Oct. 5 (Yonhap) -- LG Electronics Inc. said Friday its third-quarter operating profit moved up 44.4 percent on-year, apparently on the back of the strong returns from its TV and home appliances businesses.
39IB LGEAF LGEPF AAPL BC94 SMSN LGLD LGEJY LGEIY SMSD

 
(LEAD) LG Electronics operating profit up 44.4 pct in Q3

2018-10-05 english.yonhapnews.co.kr
SEOUL, Oct. 5 (Yonhap) -- LG Electronics Inc. said Friday its third-quarter operating profit moved up 44.4 percent on-year, apparently on the back of the strong returns from its TV and home appliances businesses.
39IB LGEAF LGEPF LGLD LGEJY LGEIY

 
LG Electronics operating profit up 44.4 pct in Q3

2018-10-05 english.yonhapnews.co.kr
SEOUL, Oct. 5 (Yonhap) -- LG Electronics Inc. said Friday its third-quarter operating profit moved up 44.4 percent on-year.
39IB LGEAF LGEPF LGLD LGEJY LGEIY

 
Seoul bourse open lower on losses in steel, chemical shares

2018-10-05 english.yonhapnews.co.kr
SEOUL, Oct. 5 (Yonhap) -- South Korea's bourse opened lower Friday following losses by steelmakers and chemical firms.
39IB LGEAF LGEPF BC94 SMSN LGLD LGEJY LGEIY SMSD

 
LG unveils V40 ThinQ with 5 cameras

2018-10-04 financialexpress
LG Electronics Inc. on Thursday unveiled its new flagship V40 ThinQ that offers five different cameras to provide a versatile and unique experience for its users.
39IB LGEAF LGEPF LGLD LGEJY LGEIY

4
Verizon Announces Availability of LG V40 ThinQ Smartphone

2018-10-04 zacks
Verizon Communications Inc. (VZ - Free Report) announced that LG Electronics Inc.’s recently launched LG V40 ThinQ will be available for pre-order starting Oct 11. This five-camera smartphone will also be available at Verizon store from Oct 18. Notably, the smartphone will be available through Verizon’s device payment option, starting from $40.83 per month on a 24-month basis. Also, customers can get the device for $979.
39IB LGEPF UZA UZC VZA UZB LGEAF CSBR WIN GJH VZ LGLD USM LGEJY TNAV LGEIY

 
LG unveils new W7 smartwatch in U.S

2018-10-04 english.yonhapnews.co.kr
SEOUL, Oct. 4 (Yonhap) -- South Korean tech firm LG Electronics Inc. has showcased a new smartwatch alongside its signature LG V40 ThinQ smartphone in the United States, industry sources in Seoul said Thursday.
39IB LGEAF LGEPF LGLD LGEJY LGEIY

1
(LEAD) Seoul stocks end sharply lower on foreign selling

2018-10-04 english.yonhapnews.co.kr
SEOUL, Oct. 4 (Yonhap) -- South Korean stocks closed sharply lower Thursday as foreigners offloaded local shares for the fourth consecutive session. The South Korean won fell against the U.S. dollar.
39IB SKMD LGEPF SKM BC94 SMSN KIMTY LGEAF KIMTF LGLD LGEJY LGEIY SMSD

1
Seoul stocks end sharply lower on foreign selling

2018-10-04 english.yonhapnews.co.kr
SEOUL, Oct. 4 (Yonhap) -- South Korean stocks closed sharply lower Thursday as foreigners offloaded local shares for the fourth consecutive session. The South Korean won fell against the U.S. dollar.
39IB SKMD LGEPF SKM BC94 SMSN KIMTY LGEAF KIMTF LGLD LGEJY LGEIY SMSD

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

CUSIP: 50186Q103